Targeting Autophagy Potentiates the Anti-Tumor Effect of PARP Inhibitor in Pediatric Chronic Myeloid Leukemia

AMB Express - Germany
doi 10.1186/s13568-019-0836-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Spautin-1, a Novel Autophagy Inhibitor, Enhances Imatinib-Induced Apoptosis in Chronic Myeloid Leukemia

International Journal of Oncology
Cancer ResearchOncology
2014English

Targeting AMPK-ULK1-mediated Autophagy for Combating BET Inhibitor Resistance in Acute Myeloid Leukemia Stem Cells

Autophagy
Cell BiologyMolecular Biology
2017English

Targeting of Plasminogen Activator Inhibitor-1 Activity Promotes Elimination of Chronic Myeloid Leukemia Stem Cells

Haematologica
Hematology
2020English

Acute Pediatric Leg Compartment Syndrome in Chronic Myeloid Leukemia

Orthopedics
SurgeryOrthopedicsSports Medicine
2014English

Asparaginase Induces Apoptosis and Cytoprotective Autophagy in Chronic Myeloid Leukemia Cells

Oncotarget
Oncology
2015English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Effect of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia (Cytogenetic, Molecular Response) in Mosul

Annals of the College of Medicine, Mosul
2018English

Multiinstitution Retrospective Review of Long Term Outcomes in Pediatric Chronic Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Chronic Myeloid Leukemia

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy